NEW YORK (GenomeWeb News) – Agilent Technologies and Sage Science today announced a co-marketing deal covering each other's technologies for next-generation sequencing applications.
The deal covers Agilent's 2100 Bioanalyzer for detecting and quantifying nucleic acids and Sage's Pippin Prep DNA size selection system. In addition to co-promoting the platforms, the partners will develop application studies that leverage the combined capabilities of the two systems.
Financial and other terms of the deal were not disclosed.
The 2100 Bioanalyzer is a microfluidics-based system for sizing, quantification, and quality control of DNA, RNA, proteins, and cells. The Pippin Prep is an electrophoretic platform for preparing size-fractionated DNA samples.
Proper preparation and quality control of the input sample and the library are crucial for achieving high-fidelity data in next-gen sequencing, the partners said in a statement. Combining the 2100 Bioanalyzer with the Pippin Prep will advance and streamline sample preparation, they added.
In October, Sage announced a co-marketing deal for its Pippin Prep system with Illumina's next-gen sequencers.